Please provide your email address to receive an email when new articles are posted on . Many patients with obesity hypoventilation syndrome are misdiagnosed as having other respiratory conditions and ...
This page lists all known medications that could potentially lead to 'Hypoventilation' as a side effect. It's important to note that mild side effects are quite common with medications. The medication ...
Congenital central hypoventilation syndrome (CCHS), a rare disorder typically presenting in the newborn period, results in over 90% of cases from PHOX2B polyalanine repeat mutations. It is ...
Sleep-related hypoventilation is a breathing-related disorder that interrupts normal sleep. This condition may be diagnosed when all other sleep disorders have been ruled out, though it may appear ...
CHICAGO -- A 5-year-old in Chicago has overcome the odds to celebrate her fifth birthday. Now, her family is raising money for her to receive life-changing surgery. When Alice Cloe was born on Nov. 22 ...
WASHINGTON, DC — When used as an adjunct to propofol during deep sedation, ketamine reduces hypoventilation and the need for rescued airway maneuvers, researchers from Northwestern University Feinberg ...
We report a case of Congenital Central Hypoventilation syndrome (CCHS), diagnosed in utero at 18 weeks’ gestation analysis of repeats in the PHOX2b gene in fetal amniocytes and confirmed at delivery.
The study covered in this summary was published in Preprints With The Lancet and has not yet been peer reviewed. Patients with diabetes who were hospitalized for diabetic ketoacidosis (DKA) had worse ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. New data on underlying conditions among people ...
Keeping all your health parameters in place is the foremost thing everyone around the world wishes today. It is crucial to look after the saturation level of oxygen in your blood which is commonly ...
The global hypoventilation management market size is expected to surpass an impressive valuation of US$ 7.1 billion in 2023 and is projected to reach US$ 11.9 billion by 2033, trailing a CAGR of 5.3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results